Mehmet V Yigit
Overview
Explore the profile of Mehmet V Yigit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
537
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Robertson N, Hizir M, Balcioglu M, Wang R, Yavuz M, Yumak H, et al.
Langmuir
. 2015 Aug;
31(36):9943-52.
PMID: 26305398
In this study we have reported our efforts to address some of the challenges in the detection of miRNAs using water-soluble graphene oxide and DNA nanoassemblies. Purposefully inserting mismatches at...
32.
Robertson N, Hizir M, Balcioglu M, Rana M, Yumak H, Ecevit O, et al.
Bioconjug Chem
. 2015 Mar;
26(4):735-45.
PMID: 25734834
Here we have demonstrated that graphene serves as a remarkable platform for monitoring the multitask activity of an enzyme with fluorescence spectroscopy. Our studies showed that four different simultaneous enzymatic...
33.
Hizir M, Balcioglu M, Rana M, Robertson N, Yigit M
ACS Appl Mater Interfaces
. 2014 Aug;
6(17):14772-8.
PMID: 25158299
Circulating oncomiRs are highly stable diagnostic, prognostic, and therapeutic tumor biomarkers, which can reflect the status of the disease and response to cancer therapy. miR-141 is an oncomiR, which is...
34.
Robertson N, Yigit M
Wiley Interdiscip Rev RNA
. 2014 Jul;
5(6):823-33.
PMID: 25044299
MicroRNAs (miRNAs) are small noncoding RNA molecules with big implications in cancer. The abnormal expression of specific miRNAs has been linked to development of many cancer types. Dysregulated miRNAs play...
35.
Balcioglu M, Rana M, Robertson N, Yigit M
ACS Appl Mater Interfaces
. 2014 Jul;
6(15):12100-10.
PMID: 25014711
We controlled the fluorescence emission of a fluorescently labeled iron oxide nanoparticle using three different nanomaterials with ultraefficient quenching capabilities. The control over the fluorescence emission was investigated via spacing...
36.
Yoo B, Ghosh S, Kumar M, Moore A, Yigit M, Medarova Z
J Biomed Nanotechnol
. 2014 Apr;
10(6):1114-22.
PMID: 24749405
The delivery of oligonucleotide antagonists to cytosolic RNA targets such as microRNA represents an avenue for the post-transcriptional control of cellular phenotype. In tumor cells, oncogenic miRNAs, termed oncomirs, are...
37.
Yoo B, Kavishwar A, Ghosh S, Barteneva N, Yigit M, Moore A, et al.
Chem Biol
. 2014 Jan;
21(2):199-204.
PMID: 24440078
We describe a technology for the profiling of miRNA expression in intact cells. The technology is based on sensor oligonucleotides that are cleavable, completely complementary to a target miRNA, and...
38.
Rana M, Balcioglu M, Robertson N, Yigit M
Analyst
. 2013 Dec;
139(4):714-20.
PMID: 24362750
Graphene oxide has gained significant attention due to its exceptional physical properties at biological interfaces. It has extraordinary quenching, fast adsorption and desorption properties that are suitable for detection of...
39.
Ghosh S, Yigit M, Uchida M, Ross A, Barteneva N, Moore A, et al.
Int J Cancer
. 2013 Oct;
134(7):1758-66.
PMID: 24114765
The clinical management of cancer reflects a balance between treatment efficacy and toxicity. While typically, combination therapy improves response rate and time to progression compared with sequential monotherapy, it causes...
40.
Yigit M, Medarova Z
Am J Nucl Med Mol Imaging
. 2012 Nov;
2(2):232-41.
PMID: 23133814
Surface enhanced Raman scattering (SERS) is a signal-increasing phenomenon that occurs whenever Raman scattering on a metal surface is enhanced many orders of magnitude. Recently SERS has received considerable attention...